Search

Author/Creator Tolaney, Sara M

1. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial. Issue 1 (January 2023)

Authors:
Johnston, Stephen R D; Toi, Masakazu; O'Shaughnessy, Joyce; Rastogi, Priya; Campone, Mario; Neven, Patrick; Huang, Chiun-Sheng; Huober, Jens; Jaliffe, Georgina Garnica; Cicin, Irfan; Tolaney, Sara M; Goetz, Matthew P; Rugo, Hope S; Senkus, Elzbieta; Testa, Laura; Del Mastro, Lucia; Shimizu, Chika...
Journal:
Lancet oncology
Issue:
Volume 24:Issue 1(2023)
Page Start:
77
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial. Issue 6 (June 2020)

Authors:
Tolaney, Sara M; Wardley, Andrew M; Zambelli, Stefania; Hilton, John F; Troso-Sandoval, Tiffany A; Ricci, Francesco; Im, Seock-Ah; Kim, Sung-Bae; Johnston, Stephen RD; Chan, Arlene; Goel, Shom; Catron, Kristen; Chapman, Sonya C; Price, Gregory L; Yang, Zhengyu; Gainford, M Corona; André, Fabrice
Journal:
Lancet oncology
Issue:
Volume 21:Issue 6(2020)
Page Start:
763
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial. Issue 3 (March 2023)

Authors:
Tolaney, Sara M; Tarantino, Paolo; Graham, Noah; Tayob, Nabihah; Parè, Laia; Villacampa, Guillermo; Dang, Chau T; Yardley, Denise A; Moy, Beverly; Marcom, P Kelly; Albain, Kathy S; Rugo, Hope S; Ellis, Matthew J; Shapira, Iuliana; Wolff, Antonio C; Carey, Lisa A; Barroso-Sousa, Romualdo; Villagra...
Journal:
Lancet oncology
Issue:
Volume 24:Issue 3(2023)
Page Start:
273
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer. Issue 10 (17th October 2022)

Authors:
Waks, Adrienne G; Keenan, Tanya E; Li, Tianyu; Tayob, Nabihah; Wulf, Gerburg M; Richardson, Edward T; Attaya, Victoria; Anderson, Leilani; Mittendorf, Elizabeth A; Overmoyer, Beth; Winer, Eric P; Krop, Ian E; Agudo, Judith; Van Allen, Eliezer M; Tolaney, Sara M
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 10(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Randomized Phase II Trial of Exercise, Metformin, or Both on Metabolic Biomarkers in Colorectal and Breast Cancer Survivors. Issue 1 (20th November 2019)

Authors:
Meyerhardt, Jeffrey A; Irwin, Melinda L; Jones, Lee W; Zhang, Sui; Campbell, Nancy; Brown, Justin C; Pollak, Michael; Sorrentino, Alexandra; Cartmel, Brenda; Harrigan, Maura; Tolaney, Sara M; Winer, Eric; Ng, Kimmie; Abrams, Thomas; Fuchs, Charles S; Sanft, Tara; Douglas, Pamela S; Hu, Frank; Lig...
Journal:
JNCI cancer spectrum
Issue:
Volume 4:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer. Issue 8 (13th August 2021)

Authors:
Emens, Leisha A; Adams, Sylvia; Cimino-Mathews, Ashley; Disis, Mary L; Gatti-Mays, Margaret E; Ho, Alice Y; Kalinsky, Kevin; McArthur, Heather L; Mittendorf, Elizabeth A; Nanda, Rita; Page, David B; Rugo, Hope S; Rubin, Krista M; Soliman, Hatem; Spears, Patricia A; Tolaney, Sara M; Litton, Jennif...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 8(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗